09/03/2024
đź’ˇ Did you know that in the United States, the annual cost of treating end-stage kidney disease (ESKD) can be as high as USD 100,000 per person? This staggering figure contrasts sharply with the USD 16,995 to USD 30,000 needed for managing early-stage chronic kidney disease (CKD).
Early detection and proactive treatment of CKD are not just about cost savings—they are about lives improved and complications prevented. When CKD is caught early, patients can avoid the physical and emotional toll of advanced kidney disease. They can stay healthier, longer, and avoid the extensive treatments that come with .
Investing in early management means fewer hospital visits, less time in dialysis, and more time living life to the fullest. Let's raise awareness and advocate for early CKD screening and intervention. It's a decision that makes financial sense and, more importantly, a decision that profoundly impacts lives.
Join us in spreading the word about the importance of early CKD management. Together, we can make a difference. đź’š
